Related Experiment Videos
The irritable bowel syndrome during pregnancy
1Division of Gastroenterology, University of Michigan Medical Center, Ann Arbor, MI, USA. whasler@umich.edu
Gastroenterology Clinics of North America
|March 15, 2003
Summary
Irritable Bowel Syndrome (IBS) is defined by symptoms like abdominal discomfort and altered bowel habits, affecting up to 22% of the population. Diagnosis relies on symptom criteria, as no specific biomarkers currently exist for IBS.
Area of Science:
- Gastroenterology
- Digestive Diseases
Background:
- Irritable Bowel Syndrome (IBS) is a functional gastrointestinal disorder characterized by abdominal discomfort and altered bowel habits.
- Currently, no specific biomarkers or diagnostic markers exist for IBS.
- The prevalence of IBS symptoms ranges from 9% to 22% in the general population.
Purpose of the Study:
- To outline the diagnostic criteria for Irritable Bowel Syndrome (IBS).
- To highlight the prevalence and clinical significance of IBS in healthcare settings.
Main Methods:
- Utilizes the Rome II criteria for defining IBS.
- Criteria include abdominal pain or discomfort for at least 12 weeks over the past 12 months.
- Requires at least two additional symptoms: pain relief with defecation, association with altered stool frequency, or association with altered stool form.
Main Results:
- IBS is diagnosed based on a constellation of specific symptoms.
- Symptoms must be present for a minimum of 12 weeks within a year.
- The condition represents a significant portion of primary care visits (12%) and gastroenterology referrals (28%).
Conclusions:
- IBS diagnosis is symptom-based, lacking objective markers.
- The Rome II criteria provide a standardized approach to identifying IBS.
- IBS is a highly prevalent digestive disorder with substantial healthcare utilization.